Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer
This study has been completed.
Study NCT00095108   Information provided by ZymoGenetics

First Received on October 29, 2004.   Last Updated on March 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melanoma
Kidney Neoplasms
Metastases
Additional conditions recognized in this trial
Carcinoma, Renal Cell
Neoplasm Metastasis
Neoplasms
More general conditions related to this trial
Adenocarcinoma
Carcinoma
Kidney Diseases
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplastic Processes
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Pathologic Processes
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
Recombinant Human Interleukin-21
Sponsors listed in this trial
ZymoGenetics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services